Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer

Volume: 22, Issue: 1
Published: Jun 11, 2020
Abstract
Background Basal-like breast cancer (BLBC) is a poorly characterised, heterogeneous disease. Patients are diagnosed with aggressive, high-grade tumours and often relapse with chemotherapy resistance. Detailed understanding of the molecular underpinnings of this disease is essential to the development of personalised therapeutic strategies. Inhibitor of differentiation 4 (ID4) is a helix-loop-helix transcriptional regulator required for mammary...
Paper Details
Title
Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer
Published Date
Jun 11, 2020
Volume
22
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.